Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corp., based in Orangevale, Calif.,
has accepted delivery of a biosensor that is proposed for use in diagnosing cholera,
tuberculosis and malaria. The sensor could be in clinical trials by 2012. Developed
in conjunction with scientists and engineers at Los Alamos National Laboratory
in New Mexico, the device could allow relatively untrained medical personnel to
detect a variety of diseases rapidly. It uses planar waveguides to bring protein-receptor
pairs into proximity with one another, thus triggering detectable fluorescence.
The company plans to commercialize the sensor, which was created through a cooperative
research and development agreement with Los Alamos National Security LLC.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024